The Treatment and Natural History of Acromegaly

Completed

• Conditions: Acromegaly; Pituitary Neoplasm

• Registration Number: NCT00001981
• Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Brief Summary

The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to acromegaly.

Detailed Description

The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up.

Study Timeline

• Study Start: 1991-10-02
• Study First Submitted: 2000-01-21
• Study First Submitted QC: 2000-01-21
• Study First Posted: 2000-01-24
• Status Verified: 2020-11
• Primary Completion: 2020-11-20
• Study Completion: 2020-11-20
• Last Update Submitted: 2020-11-24
• Last Update Posted: 2020-11-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
resolution of IGF-1 Growth Hormone abnormality	every 6 months & at end of study	resolution of IGF-1 abnormality

Trial Locations

Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike; 🇺🇸 Bethesda, Maryland, United States